Innate Pharma SA
IPHA · NYSE
$1.50+$0.00 (+0.00%)TodayMarket closed ·
Prev close $1.50
Who owns IPHA
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 27.8% of IPHA’s shares.
- Sanofi SA7.5%
- AstraZeneca PLC7.0%
- Caisse des Dépôts et Consignations5.7%
- Candriam Luxembourg S.A.4.7%
- Next 6 largest institutions2.9%
- All other shareholders72.2%
| Holder | Shares | % of shares |
|---|---|---|
| Sanofi SA | 8.35M | 7.47% |
| AstraZeneca PLC | 7.83M | 7.00% |
| Caisse des Dépôts et Consignations | 6.39M | 5.72% |
| Candriam Luxembourg S.A. | 5.21M | 4.66% |
| Innate Pharma SA Employees | 2.19M | 1.96% |
| Morel (Yannis) | 374.19K | 0.33% |
| Vivier (Eric) | 285.91K | 0.26% |
| Generali Investments Partners S.p.A. SGR | 150.00K | 0.13% |
| Belzunce (Odile) | 136.25K | 0.12% |
| Laurent (Odile) | 113.66K | 0.10% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Candriam Equities L Oncology | 4.17M | 3.74% |
| Belfius Equities Cure | 1.03M | 0.92% |
| Generali France PME ETI | 150.00K | 0.13% |
| GF Ambition Solidaire | 99.82K | 0.09% |
| SG Actions Sante Europe | 63.19K | 0.06% |
Short interest
Settled Sep 30, 2026
- Shares short
- 88.62K
- Days to cover
- 1.25
- % of shares outstanding
- 0.08%
- Average daily volume
- 71.10K
- Change since last report
- +16.5%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.